seed
Stage
1
Investors
About
Re-Aim Therapeutics is listed in Syncona's portfolio as a pre-clinical therapeutics company. It is a biotechnology firm focused on developing therapeutic candidates (pre-clinical stage).
Explore Re-Aim Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.